Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma

J Biol Chem. 2006 Apr 7;281(14):9482-9. doi: 10.1074/jbc.M504489200. Epub 2006 Feb 6.

Abstract

beta1,4-galactosyltransferase V (GalT V; EC 2.4.1.38) can effectively galactosylate the GlcNAcbeta1-->6Man arm of the highly branched N-glycans that are characteristic of glioma. Previously, we have reported that the expression of GalT V is increased in the process of glioma. However, currently little is known about the role of GalT V in this process. In this study, the ectopic expression of GalT V could promote the invasion and survival of glioma cells and transformed astrocytes. Furthermore, decreasing the expression of GalT V in glioma cells promoted apoptosis, inhibited the invasion and migration and the ability of tumor formation in vivo, and reduced the activation of AKT. In addition, the activity of GalT V promoter could be induced by epidermal growth factor, dominant active Ras, ERK1, JNK1, and constitutively active AKT. Taken together, our results suggest that GalT V functioned as a novel glioma growth activator and might represent a novel target in glioma therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Brain Neoplasms / enzymology*
  • Brain Neoplasms / pathology
  • Cell Movement
  • Cell Proliferation
  • Enzyme Activation
  • Galactosyltransferases / biosynthesis*
  • Galactosyltransferases / metabolism*
  • Gene Expression Profiling
  • Glioma / enzymology*
  • Glioma / pathology
  • Humans
  • Neoplasm Invasiveness
  • Promoter Regions, Genetic
  • Tumor Cells, Cultured

Substances

  • Galactosyltransferases
  • beta-1,4-galactosyltransferase V